Pancreatic atrophy after allogeneic peripheral blood stem cell transplantation
Central nervous system Hodgkin lymphoma developing during systemic chemotherapy
Understanding chronic neutropenia: life is short
Recent advances in the management of AL Amyloidosis
Guidelines for the diagnosis and management of adult aplastic anaemia
Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601
ELANE mutant–specific activation of different UPR pathways in congenital neutropenia
The long-term outcome of patients in the LRF CLL4 trial: the effect of salvage treatment and biological markers in those surviving 10 years
Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDS
Delineating outcomes of patients with diffuse large b cell lymphoma using the national comprehensive cancer network-international prognostic index and positron emission tomography-defined remission status; a population-based analysis
In vivo reversal of the anticoagulant effect of rivaroxaban with four-factor prothrombin complex concentrate
Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study
Risk factor analysis of cerebral white matter hyperintensities in children with sickle cell disease
Antifungal stewardship: towards defining safe stopping criteria for therapeutic oral azoles
Reduced doses of cladribine and cytarabine regimen was effective and well tolerated in patients with refractory-risk multisystem Langerhans cell histiocytosis
Biomodulatory metronomic therapy induces PET-negative remission in chemo- and brentuximab-refractory Hodgkin lymphoma
High serum sclerostin levels in children with haemophilia A
A rare but recurrent t(8;13)(q24;q14) translocation in B-cell chronic lymphocytic leukaemia causing MYC up-regulation and concomitant loss of PVT1 , miR-15/16 and DLEU7
The issue of consent in medical practice